Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • Practice Guidelines
    • Featured Practice Guidelines
    • Updated Preeclampsia...

    Updated Preeclampsia Ultrasound Clinical Practice Guidelines (2018)

    Written by Vinay Singh singh Published On 2018-12-23T19:00:20+05:30  |  Updated On 23 Dec 2018 7:00 PM IST
    Updated Preeclampsia Ultrasound Clinical Practice Guidelines (2018)

    The International Society of Ultrasound in Obstetrics and Gynecology has released updated guidelines on preeclampsia ultrasound.


    Preeclampsia is a disorder of widespread vascular endothelial malfunction and vasospasm that occurs after 20 weeks' gestation and can present as late as 4-6 weeks postpartum. It is clinically defined by hypertension and proteinuria, with or without pathologic edema.


    The medical consensus is lacking regarding the values that define preeclampsia, but reasonable criteria in a woman who was normotensive before 20 weeks' gestation include systolic blood pressure (SBP) greater than 140 mm Hg and a diastolic BP (DBP) greater than 90 mm Hg on two successive measurements, 4 hours apart.


    Read Also: High-dose calcium during pregnancy may prevent preeclampsia


    Ultrasonography is used to assess the status of the fetus as well as to evaluate for growth restriction (typically asymmetrical—use abdominal circumference). Apart from transabdominal ultrasonography, umbilical artery Doppler ultrasonography should be performed to assess blood flow. The value of Doppler ultrasonography in other fetal vessels has not been demonstrated.


    Recommendation on Preeclampsia ultrasound are as follows:




    • The pulsatility index (PI) should be used for examination of uterine artery resistance in the context of preeclampsia (PE) screening.

    • Doppler examination of the uterine arteries at 11 + 0 to 13 + 6 weeks can be performed either transabdominal or transvaginally, according to local preferences and resources.

    • Because maternal factors can affect uterine artery PI, the inclusion of uterine artery PI in a multifactorial screening model should be preferred over its use as a standalone test with absolute cut‐offs, whenever feasible.

    • Mean uterine artery PI should be the Doppler index of choice for first-trimester screening.

    • Doppler examination of the uterine arteries at the second‐trimester scan can be performed either transabdominal or transvaginally. Read Also: Preeclampsia increases risk of heart disease, stroke in future: JACC
      Mean uterine artery PI should be used for prediction of PE. In the case of a unilateral placenta, a unilaterally increased PI does not appear to increase the risk for PE if the mean PI is within normal limits.

    • Although uterine artery velocimetry can be assessed transvaginally, the most common method of uterine artery Doppler examination in the third trimester is a transabdominal approach.

    • The most efficient screening model for identification of women at risk of PE seems to be a combination of maternal factors, maternal mean arterial blood pressure, uterine artery Doppler, and placental growth factor (PlGF) level at 11-13 weeks.

    • There is convincing evidence that low‐dose aspirin can significantly decrease the risk of early PE when begun at first‐trimester screening.


    For full information log on to 10.1002/uog.20105

    blood pressureBPdiastolicDoppleredemaendothelialHypertensionInternational Society of Ultrasound in Obstetrics and GynecologyPIpostpartumpreeclampsiaproteinuriapulsatility indexscreeningsonographysystolictransabdominaltransvaginallytrimesterUltrasonographyUltrasounduterineuterine artery velocimetry
    Source : With inputs from ISUOG

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Vinay Singh singh
    Vinay Singh singh
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok